FDA 483 - Nordmark Arzneimittel GMBH & Co. KG - February 13, 2017
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Nordmark Arzneimittel GmbH & Co. KG in Utersen, Germany, received a Form 483 following a February 2017 inspection. Observations included failures in equipment maintenance plans, the use of un-validated electronic records for critical manufacturing calculations, and inadequate routine monitoring for cleaning validation of non-dedicated equipment. These issues indicate significant concerns regarding quality control and data integrity in drug substance and product manufacturing.
ID · eef74cad-0c2c-43b0-bf4b-3616c0a31761